EMvision Medical Devices Ltd (ASX: EMV) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

EMvision Medical Devices Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $140.15 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 77.43 million
Earnings per share -0.101
Dividend per share N/A
Year To Date Return -32.46%
Earnings Yield N/A
Franking N/A
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

EMvision Medical Devices Ltd (ASX: EMV)
Latest News

A smiling woman looks at her computer laptop in her home with warm lights in the background feeling happy to see the EMvision share price rising
Healthcare Shares

EMvision share price rockets 11% on $5 million pay day

Shares in the Australian medical device company shot higher today.

Read more »

A guy wearing glasses tries to show off his muscles.
Technology Shares

Here’s why the EMvision share price surged 8% on Wednesday

Investors appear happy about an agreement EMvision has struck with tech company Keysight Technologies.

Read more »

A man in a white coat holds a laptop in one hand and his head in the other, it's bad news.
Healthcare Shares

EMvision (ASX:EMV) share price slides 5% following FDA update

The FDA's feedback is critical in EMvision's growth narrative.

Read more »

Jumping asx share price represented by young girl smiling and jumping up
Share Gainers

EMvision (ASX:EMV) share price leaps 14% on product update

The next step in product development has been made by EMvision...

Read more »

A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition
Healthcare Shares

The EMvision (ASX:EMV) share price jumped today. Here’s why

The EMVision (ASX: EMV) share price was on the rise today following news of two technology breakthrough from the company.…

Read more »

a doctor looking up at question marks
Healthcare Shares

Why is the EMvision (ASX:EMV) share price surging 12% this week?

The EMvision (ASX:EMV) share price is rising today, adding to significant gains on the ASX this week. Let's take a…

Read more »

Rising healthcare ASX share price represented by doctor giving thumbs up
Share Market News

Why the EMvision (ASX: EMV) share price closed 13% higher today

The EMvision (ASX: EMV) share price finished 13% higher today after the company announced grant success. Here's the rundown.

Read more »

asx share price in trading halt represented by business man stopping falling row of dominoes
Share Market News

Why the EMvision (ASX:EMV) share price is going nowhere

The EMvision (ASX:EMV) share price is unchanged today after the company announced a trading halt on Friday. We take a…

Read more »

EMV ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About EMvision Medical Devices Ltd

EMvision Medical Devices Ltd is an Australian medical device company. The company is primarily focused on the development and commercialization of medical imaging and diagnostic technology. It is seeking to commercialize a potentially low-cost, portable, medical imaging device using electromagnetic microwave imaging for stroke diagnosis and monitoring and other medical imaging needs.

EMV Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
20 May 2022 $1.81 $-0.02 -1.09% 38,095 $1.83 $1.87 $1.81
19 May 2022 $1.83 $0.01 0.55% 50,718 $1.78 $1.85 $1.73
18 May 2022 $1.82 $0.09 5.20% 131,861 $1.81 $1.92 $1.77
16 May 2022 $1.73 $-0.05 -2.80% 8,343 $1.78 $1.78 $1.73
13 May 2022 $1.79 $-0.03 -1.65% 86,254 $1.80 $1.80 $1.66
12 May 2022 $1.82 $-0.04 -2.16% 9,980 $1.80 $1.82 $1.77
11 May 2022 $1.85 $0.04 2.21% 29,261 $1.83 $1.85 $1.77
10 May 2022 $1.81 $-0.03 -1.63% 61,157 $1.84 $1.84 $1.72
09 May 2022 $1.84 $-0.09 -4.66% 40,691 $1.93 $1.93 $1.84
06 May 2022 $1.93 $-0.02 -1.03% 31,175 $1.94 $1.97 $1.93
05 May 2022 $1.95 $-0.05 -2.51% 37,778 $2.04 $2.04 $1.93
04 May 2022 $2.00 $0.06 3.09% 73,366 $2.11 $2.11 $2.00
29 Apr 2022 $1.94 $-0.06 -3.01% 33,621 $2.00 $2.03 $1.94
28 Apr 2022 $2.00 $0.05 2.56% 7,140 $1.97 $2.04 $1.96
27 Apr 2022 $1.95 $-0.09 -4.41% 56,960 $2.05 $2.08 $1.92
26 Apr 2022 $2.04 $-0.01 -0.49% 15,190 $2.05 $2.06 $2.03
22 Apr 2022 $2.05 $-0.04 -1.91% 6,040 $2.07 $2.11 $2.05
21 Apr 2022 $2.09 $-0.03 -1.42% 45,605 $2.09 $2.11 $2.02

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
04 Feb 2022 John Keep Buy 12 $25,227
On-market trade.
10 Jan 2022 Scott Kirkland Buy 7 $20,049
On-market trade.
22 Dec 2021 Scott Kirkland Cancelled 79 $201,282
Cancellation of securities.
22 Dec 2021 Scott Kirkland Exercise 520 $210,000
Exercise of options. VWAP
22 Dec 2021 Scott Kirkland Buy 520 $210,000
Exercise of options. VWAP
22 Dec 2021 Ronald (Ron) Weinberger Exercise 867 $350,000
Exercise of options. VWAP
22 Dec 2021 Ronald (Ron) Weinberger Buy 867 $350,000
Exercise of options. VWAP
22 Dec 2021 Ronald (Ron) Weinberger Cancelled 132 $335,470
Cancellation of securities.
22 Dec 2021 Anthony (Tony) Keane Exercise 500 $175,000
Exercise of options.
22 Dec 2021 Anthony (Tony) Keane Buy 500 $175,000
Exercise of options.
22 Dec 2021 Geoffrey (Geoff) Pocock Exercise 500 $175,000
Exercise of options.
22 Dec 2021 Geoffrey (Geoff) Pocock Buy 500 $175,000
Exercise of options.
22 Dec 2021 John Keep Exercise 347 $140,000
Exercise of options. VWAP
22 Dec 2021 John Keep Cancelled 52 $134,188
Cancellation of securities.
22 Dec 2021 John Keep Buy 347 $140,000
Exercise of options. VWAP

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Dr Phillip James Dubois Non-Executive Director Sep 2020
Dr Dubois is an imaging executive and neuroradiologist has joined the board as an independent Non-executive Director. Dr Dubois is a former CEO of their imaging division and served as Executive Director from 2001 to 2020. He is also the founder and former CEO and Chairman of Queensland X-Ray. Dr Dubois is currently an Associate Professor of Radiology at the University of Queensland Medical School. He has served on numerous government and radiology group bodies, including the councils of the Royal Australian and New Zealand College of Radiologists and the Australian Medical Association, and as Vice-President of the Australian Diagnostic Imaging Association. Dr Dubois is a Non executive Director of Magnetica Limited.
Dr Ronald (Ron) Peter Weinberger Chief Executive OfficerManaging Director May 2020
Dr Weinberger has more than 20 years experience in medical research, biotechnology and commercialization. Dr Weinberger joined Nanosonics in August 2004 and was appointed as Executive Director in July 2008 then Managing Director and Chief Executive Officer December 2011 with a period as acting CEO from May 2011. From October 2013 to February 2018, Dr Weinberger was responsible for the direction of Nanosonics technology development and commercialisation strategy. He is coinventor of several of Nanosonics key technology patents.
Mr Anthony (Tony) Keane Non-Executive Director Jun 2018
Mr Keane is an experienced business and finance executive and holds a number of independent non executive director and advisory board roles. Mr Keane also undertakes finance advisory and consultancy assignments for various business clients and previously held numerous roles with a major trading bank principally in business, corporate and institutional banking. Mr Keane is currently an Independent Non-Executive Director of National Storage Holdings Ltd, the holding company established for National Storage REIT, the first independent, internally managed and fully-integrated owner and operator of selfstorage centres listed on the ASX and director of Queensland Symphony Orchestra Holdings Ltd, Queensland's largest performing arts company and only professional symphony orchestra. He is the Chair of Risk Committee.
Mr Geoffrey (Geoff) Richard Pocock Non-Executive Director Mar 2018
Mr Pocock has experience as a corporate advisor and strategy consultant advising companies on commercialisation and IP management, business development, mergers and acquisitions strategy and raising equity capital from private and public equity markets. Mr Pocock is currently the principal of Polaris Consulting (WA) Pty Ltd. Mr Pocock previously spent several years as a research scientist in the biopharmaceutical industry in Australia and the United Kingdom. He is member of Risk Committee.
Mr John Keep Non-Executive ChairmanNon-Executive Director Mar 2018
Mr Keep has public company board experience as well as senior management experience in the healthcare and hospitality sectors including managing start up enterprises and medical diagnostic companies. Mr Keep led the successful restructuring and revitalization of the radiology company Queensland Diagnostic Imaging, Queensland's leading private radiology and diagnostic imaging group and at Lemarne Healthcare, a company specialising in the detection and treatment of skin cancer. Mr Keep is a director of Queensland Symphony Orchestra Holdings Ltd and a member of that company's Finance Audit and Risk Committee.
Mr Scott Kirkland Co-founderExecutive Director Jul 2017
Mr Kirkland has held several senior sales positions, including Head of Client Sales at Quantcast, a US-based technology company. Mr Kirkland is a co-founder of the Company and oversees its corporate affairs, commercial strategy and business development efforts.
Ms Emma Waldon Chief Financial OfficerCompany Secretary
-
Emma Waldon Chief Financial OfficerCompany Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Ryan Michael Laws 3,350,000 4.60%
Mr Scott Philip Kirkland 3,333,400 4.57%
Neweconomy Com Au Nominees Pty Limited <900 Account> 1,800,937 2.47%
Truebell Capital Pty Ltd <Truebell Investment Fund> 1,750,110 2.40%
Uniquest Pty Limited 1,200,000 1.65%
Glensburg Pty Ltd <Tyto Corp Pension Fund A/C> 1,100,000 1.51%
Jm Starcevich Investments Pty Ltd 1,089,000 1.49%
Dr Stuart Crozier 1,044,937 1.43%
Dr Ronald Peter Weinberger 1,017,200 1.40%
Mr Bryant James Mclarty <The Mclarty Family A/C> 1,002,500 1.38%
Mr Martin Kolev 1,000,000 1.37%
Mr Paul Raymond Brown & Mrs Angelique Susan Brown <Brown Family A/C> 990,000 1.36%
Walsh Prestige Pty Ltd <Walsh Family A/C> 900,000 1.23%
Mr Vincent Michael O'Sullivan <O'Sullivan A/C> 883,000 1.21%
Hillridge Pty Ltd 871,248 1.20%
Wakil Family Group Pty Ltd <Ron Ton Fashions P/L Rp A/C> 852,437 1.17%
Kong Pak Lim 805,500 1.10%
Pit2 Co Pty Ltd <Power Investment 2 A/C> 741,298 1.02%
Wandeera Investments Pty Ltd <Hippopotamus Superannuation Fund A/C> 735,000 1.01%
Forza Management Pty Ltd <The Forza Future A/C> 672,500 0.92%

Profile

since

Note